Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

INZY holding history

Inozyme Pharma, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

INZY overviewAll 13F holders of INZYFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of INZY by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−1,221,125−100.0%Sold outHolders
Q2 20251,221,125$4.89M<0.1%−9,640−0.8%ReducedHolders
Q1 20251,230,765$1.12M<0.1%+51,143+4.3%AddedHolders
Q4 20241,179,622$3.27M<0.1%+8,450+0.7%AddedHolders
Q3 20241,171,172$6.13M<0.1%+19,499+1.7%AddedHolders
Q2 20241,151,673$5.14M<0.1%+84,194+7.9%AddedHolders
Q1 20241,067,479$8.18M<0.1%+34,763+3.4%AddedHolders
Q4 20231,032,716$4.40M<0.1%+209,893+25.5%AddedHolders
Q3 2023822,823$3.46M<0.1%+205,364+33.3%AddedHolders
Q2 2023617,459$3.44M<0.1%+376,251+156.0%AddedHolders
Q1 2023241,208$1.38M<0.1%+8,082+3.5%AddedHolders
Q4 2022233,126$244.0K<0.1%−559−0.2%ReducedHolders
Q3 2022233,685$626.0K<0.1%+16,760+7.7%AddedHolders
Q2 2022216,925$1.03M<0.1%+30,918+16.6%AddedHolders
Q1 2022186,007$760.0K<0.1%+1,988+1.1%AddedHolders
Q4 2021184,019$1.25M<0.1%−14,605−7.4%ReducedHolders
Q3 2021198,624$2.30M<0.1%+18,952+10.5%AddedHolders
Q2 2021179,672$3.06M<0.1%+29,311+19.5%AddedHolders
Q1 2021150,361$2.98M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.